vs
Astrana Health, Inc.（ASTH）与CISO Global, Inc.（CISO）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是CISO Global, Inc.的151.6倍（$950.5M vs $6.3M）。Astrana Health, Inc.净利率更高（0.7% vs -35.4%，领先36.1%）。Astrana Health, Inc.同比增速更快（42.9% vs -15.4%）。过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -11.6%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
CISO Global Inc.是专业网络安全服务商，提供托管安全监测、风险评估、合规咨询、事件响应、终端防护等服务，面向北美市场的中小企业、政府机构及商业客户，覆盖医疗、零售、金融等领域，助力客户保护数字资产、抵御网络风险。
ASTH vs CISO — 直观对比
营收规模更大
ASTH
是对方的151.6倍
$6.3M
营收增速更快
ASTH
高出58.2%
-15.4%
净利率更高
ASTH
高出36.1%
-35.4%
两年增速更快
ASTH
近两年复合增速
-11.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $6.3M |
| 净利润 | $6.6M | $-2.2M |
| 毛利率 | — | 28.6% |
| 营业利润率 | 1.9% | -33.7% |
| 净利率 | 0.7% | -35.4% |
| 营收同比 | 42.9% | -15.4% |
| 净利润同比 | 184.4% | 59.8% |
| 每股收益（稀释后） | $0.12 | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHCISO
| Q4 25 | $950.5M | $6.3M | ||
| Q3 25 | $956.0M | $6.5M | ||
| Q2 25 | $654.8M | $6.7M | ||
| Q1 25 | $620.4M | $7.2M | ||
| Q4 24 | $665.2M | $7.4M | ||
| Q3 24 | $478.7M | $7.5M | ||
| Q2 24 | $486.3M | $7.8M | ||
| Q1 24 | $404.4M | $8.0M |
净利润ASTHCISO
| Q4 25 | $6.6M | $-2.2M | ||
| Q3 25 | $373.0K | $2.5M | ||
| Q2 25 | $9.4M | $-3.0M | ||
| Q1 25 | $6.7M | $-5.4M | ||
| Q4 24 | $-7.8M | $-5.5M | ||
| Q3 24 | $16.1M | $-3.7M | ||
| Q2 24 | $19.2M | $-8.4M | ||
| Q1 24 | $14.8M | $-6.6M |
毛利率ASTHCISO
| Q4 25 | — | 28.6% | ||
| Q3 25 | — | 24.9% | ||
| Q2 25 | — | 24.4% | ||
| Q1 25 | — | 24.9% | ||
| Q4 24 | — | 24.8% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 12.0% | ||
| Q1 24 | — | 8.8% |
营业利润率ASTHCISO
| Q4 25 | 1.9% | -33.7% | ||
| Q3 25 | 2.0% | -40.8% | ||
| Q2 25 | 3.1% | -34.7% | ||
| Q1 25 | 3.3% | -23.9% | ||
| Q4 24 | 0.1% | -26.1% | ||
| Q3 24 | 5.9% | -46.8% | ||
| Q2 24 | 6.2% | -54.3% | ||
| Q1 24 | 7.5% | -61.0% |
净利率ASTHCISO
| Q4 25 | 0.7% | -35.4% | ||
| Q3 25 | 0.0% | 39.2% | ||
| Q2 25 | 1.4% | -44.8% | ||
| Q1 25 | 1.1% | -75.1% | ||
| Q4 24 | -1.2% | -74.5% | ||
| Q3 24 | 3.4% | -49.0% | ||
| Q2 24 | 3.9% | -108.0% | ||
| Q1 24 | 3.7% | -82.4% |
每股收益（稀释后）ASTHCISO
| Q4 25 | $0.12 | $0.10 | ||
| Q3 25 | $0.01 | $-0.05 | ||
| Q2 25 | $0.19 | $-0.09 | ||
| Q1 25 | $0.14 | $-0.38 | ||
| Q4 24 | $-0.14 | $-0.47 | ||
| Q3 24 | $0.33 | $-0.32 | ||
| Q2 24 | $0.40 | $-0.69 | ||
| Q1 24 | $0.31 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $1.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $14.8M |
| 总资产 | $2.2B | $25.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHCISO
| Q4 25 | $429.5M | $1.7M | ||
| Q3 25 | $463.4M | $1.1M | ||
| Q2 25 | $342.1M | $760.8K | ||
| Q1 25 | $260.9M | $1.8M | ||
| Q4 24 | $290.8M | $992.6K | ||
| Q3 24 | $350.3M | $443.1K | ||
| Q2 24 | $327.7M | $1.1M | ||
| Q1 24 | $337.3M | $1.5M |
总债务ASTHCISO
| Q4 25 | — | — | ||
| Q3 25 | — | $2.1M | ||
| Q2 25 | — | $9.9M | ||
| Q1 25 | — | $10.6M | ||
| Q4 24 | — | $11.7M | ||
| Q3 24 | — | $11.9M | ||
| Q2 24 | — | $12.8M | ||
| Q1 24 | — | $15.1M |
股东权益ASTHCISO
| Q4 25 | $779.3M | $14.8M | ||
| Q3 25 | $775.5M | $16.3M | ||
| Q2 25 | $765.5M | $7.6M | ||
| Q1 25 | $745.4M | $7.0M | ||
| Q4 24 | $712.7M | $1.1M | ||
| Q3 24 | $704.6M | $3.0M | ||
| Q2 24 | $678.9M | $5.6M | ||
| Q1 24 | $653.5M | $11.2M |
总资产ASTHCISO
| Q4 25 | $2.2B | $25.0M | ||
| Q3 25 | $2.2B | $25.1M | ||
| Q2 25 | $1.4B | $25.8M | ||
| Q1 25 | $1.3B | $27.8M | ||
| Q4 24 | $1.4B | $26.7M | ||
| Q3 24 | $1.3B | $26.6M | ||
| Q2 24 | $1.3B | $43.2M | ||
| Q1 24 | $1.2B | $47.5M |
负债/权益比ASTHCISO
| Q4 25 | — | — | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 1.31× | ||
| Q1 25 | — | 1.52× | ||
| Q4 24 | — | 10.20× | ||
| Q3 24 | — | 3.92× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $-1.8M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHCISO
| Q4 25 | $-2.9M | $-1.8M | ||
| Q3 25 | $10.0M | $-876.7K | ||
| Q2 25 | $90.9M | $-2.3M | ||
| Q1 25 | $16.6M | $-3.0M | ||
| Q4 24 | $-10.9M | $-259.0K | ||
| Q3 24 | $34.0M | $-903.1K | ||
| Q2 24 | $23.2M | $-1.3M | ||
| Q1 24 | $6.0M | $-1.4M |
自由现金流ASTHCISO
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | $-1.3M | ||
| Q1 24 | $5.6M | $-1.5M |
自由现金流率ASTHCISO
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | -16.4% | ||
| Q1 24 | 1.4% | -18.5% |
资本支出强度ASTHCISO
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | 0.0% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 0.6% | 0.1% | ||
| Q1 24 | 0.1% | 0.9% |
现金转化率ASTHCISO
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | -0.35× | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CISO
暂无分部数据
